Ambalal Sarabhai Enterprises Limited has closed its trading window for dealing in company securities starting October 1, 2026. The closure will remain in effect until 48 hours after the declaration of financial results for the quarter ended September 30, 2026.

This action is taken in compliance with the Company's Code of Conduct for Prohibition of Insider Trading and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. The restriction applies to all specified designated persons of the company during this period.

Compliance and Restrictions

The company has advised all connected and designated persons, along with their relatives, not to trade in the securities of the company during the aforesaid period of closure. This measure ensures adherence to regulatory standards regarding insider information handling prior to public disclosure of financial performance.

The specific date for the Board of Directors meeting to approve the financial results for the quarter ended September 30, 2026, will be informed in due course. The notification was signed by Disha Punjani, Company Secretary and Compliance Officer, on September 25, 2026.

Ambalal Sarabhai Enterprises reported a consolidated net profit of ₹3.98 crore for the quarter ended June 30, 2026 (Q1FY27), marking a 52% decline year-on-year from ₹8.22 crore in Q1FY26. While revenue from operations grew 8% to ₹43.56 crore, the bottom line was pressured by a sharp contraction in other income and softer operating performance across key segments.

The company’s Board of Directors approved the unaudited standalone and consolidated financial results on August 12, 2026. The statutory auditors, Sorab S. Engineer & Co., issued an unqualified review report on the interim financial information.

Consolidated Financial Performance

Consolidated revenue from operations rose to ₹43.56 crore in Q1FY27, up from ₹40.34 crore in the corresponding quarter of FY26. However, total income fell 6% to ₹45.59 crore, primarily due to a steep drop in other income.

Other income plummeted 76% to ₹2.03 crore from ₹8.36 crore in Q1FY26. This decline was largely attributable to the absence of a one-time gain recognized in the prior year; notes to the accounts reveal that Q1FY26 included ₹6.65 crore from past obligations regarding sales tax and custom duty that were no longer required. Excluding this non-recurring item, operational revenue growth remained modest.

Profit before tax stood at ₹46.79 crore, down from ₹79.34 crore in Q1FY26. Finance costs decreased slightly to ₹97.77 lakh from ₹100.62 lakh, while employee benefits expenses rose marginally to ₹75.64 lakh from ₹73.77 lakh.

Segment-wise Analysis

The group operates through two primary segments: Pharmaceuticals and Electronics. Both segments saw mixed performance in terms of revenue and profitability.

Pharmaceuticals revenue remained flat at ₹25.26 crore compared to ₹25.46 crore in Q1FY26. However, the segment’s result before interest and tax dropped significantly to ₹43.85 lakh from ₹83.78 lakh in the prior year, indicating margin compression despite stable sales volumes.

Electronics revenue grew 23% to ₹18.33 crore from ₹14.87 crore, driven by higher order inflows or pricing adjustments not detailed in the filing. Nevertheless, the segment’s profitability declined to ₹12.72 lakh from ₹56.25 lakh in Q1FY26, suggesting that cost structures or mix shifts eroded gains from top-line growth.

What the Numbers Show

A critical divergence exists between top-line growth and profitability. While consolidated revenue increased by 8%, net profit halved. This disconnect is primarily driven by the absence of ₹6.65 crore in one-time other income recorded in Q1FY26. Furthermore, both reportable segments—Pharmaceuticals and Electronics—experienced significant declines in their pre-interest and tax results, falling by 48% and 77% respectively. This indicates underlying operational margin pressure across the group, independent of the non-recurring income fluctuation.

Standalone Results

On a standalone basis, Ambalal Sarabhai Enterprises reported a negligible net profit of ₹3.01 lakh for Q1FY27, down sharply from ₹6.88 crore in Q1FY26. Standalone revenue from operations fell 67% to ₹54.37 lakh from ₹16.36 crore, reflecting the holding company structure where most operating activities are consolidated through subsidiaries. Other income also declined to ₹16.97 lakh from ₹81.71 lakh, again impacted by the prior year’s one-time tax duty refunds.